ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Sevilla, AN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Sevilla, AN, ESP:

A Trial of Immunotherapy Strategies in Metastatic Hormone-sensitive Prostate Cancer

Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Drug: Docetaxel
Drug: Nivolumab 10 MG/ML

Phase 2, Phase 3

Spanish Oncology Genito-Urinary Group

Sevilla, Spain and 29 other locations

and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: abiraterone acetate
Drug: olaparib

Phase 3

AstraZeneca
AstraZeneca

Sevilla, Spain and 131 other locations

enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate...

Active, not recruiting
Metastatic Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Drug: Tazemetostat
Drug: Abiraterone/prednisone

Phase 1, Phase 2

Epizyme

Jerez De La Frontera, Cadiz, Spain and 23 other locations

patients with progressive metastatic castration-resistant prostate cancer (mCRPC).The following assessment of prostate cancer...

Active, not recruiting
Castration-resistant Prostate Cancer
Prostate Cancer Metastatic
Drug: Enzalutamide
Drug: HC-1119

Phase 3

Hinova Pharmaceuticals

Sevilla, Spain and 57 other locations

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...

Active, not recruiting
Prostatic Neoplasms
Drug: Apalutamide
Drug: Placebo

Phase 3

Aragon Pharmaceuticals

Sevilla N/a, Spain and 388 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Enrolling
Prostate Cancer
Drug: docetaxel
Drug: capivasertib

Phase 3

AstraZeneca
AstraZeneca

Sevilla, Spain and 249 other locations

to radiographic progression-free survival (rPFS) per 1) Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 for soft tissue and/or Prostate...

Active, not recruiting
Hormone-Sensitive Prostate Cancer
Drug: Capivasertib
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Sevilla, Spain and 322 other locations

in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...

Active, not recruiting
Prostatic Neoplasms
Drug: Bicalutamide Placebo
Radiation: 74-80 Grays (units of radiation)

Phase 3

Aragon Pharmaceuticals

Sevilla, Spain and 271 other locations

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...

Enrolling
Prostate Cancer
Drug: Radium-223
Drug: Docetaxel 60 mg/m2

Phase 3

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Sevilla, Spain and 63 other locations

be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to t...

Enrolling
Prostate Cancer Recurrent
Androgen-Resistant Prostatic Cancer
Drug: docetaxel
Drug: Prednisone

Phase 2

MacroGenics
MacroGenics

Sevilla, Spain and 50 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems